Skip to Content

MYLAN MSA 375 MYLAN MSA 375 (Mesalamine Extended-Release 375 mg (0.375 g))

Pill with imprint MYLAN MSA 375 MYLAN MSA 375 is Green, Capsule-shape and has been identified as Mesalamine Extended-Release 375 mg (0.375 g). It is supplied by Mylan Pharmaceuticals Inc..

Mesalamine is used in the treatment of crohn's disease, maintenance; inflammatory bowel disease; ulcerative colitis, maintenance; ulcerative colitis; ulcerative proctitis and belongs to the drug class 5-aminosalicylates. Excluding Asacol and Asacol HD: There is no proven risk in humans during pregnancy. Asacol and Asacol HD: Risk cannot be ruled out during pregnancy. Mesalamine 375 mg (0.375 g) is not a controlled substance under the Controlled Substances Act (CSA).

Images for MYLAN MSA 375 MYLAN MSA 375

Mesalamine extended-release 375 mg (0.375 g) MYLAN MSA 375 MYLAN MSA 375

Mesalamine Extended-Release

Imprint
MYLAN MSA 375 MYLAN MSA 375
Strength
375 mg (0.375 g)
Color
Green
Shape
Capsule-shape
Availability
Prescription only
Drug Class
5-aminosalicylates
Pregnancy Category
B - No proven risk in humans - excluding Asacol and Asacol HD, C - Risk cannot be ruled out - Asacol and Asacol HD
CSA Schedule
Not a controlled drug
Labeler / Supplier
Mylan Pharmaceuticals Inc.
National Drug Code (NDC)
00378-1375

Get help with Imprint Code FAQs.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.